News Feature


Nature Biotechnology 26, 151 - 154 (2008)
doi:10.1038/nbt0208-151

Priced out of the UK market

Nuala Moran1

  1. London


Is NICE's approach to cost-effectiveness turning the UK into a biotech-free zone? Nuala Moran investigates.

Top



Extra navigation

Search PubMed for

Open Innovation Challenges

naturejobs

ADVERTISEMENT